Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 195,127 shares at $1.80 ($356K) on 2016-08-30, disclosed to the SEC on 2016-09-01.
Open-market sale of $356k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.80 | 23,500 | $42K | 11.9% |
| 2 | $1.80 | 1,500 | $3K | 0.8% |
| 3 | $1.81 | 1,500 | $3K | 0.8% |
| 4 | $1.81 | 30,474 | $55K | 15.5% |
| 5 | $1.81 | 200 | $362 | 0.1% |
| 6 | $1.81 | 200 |
| $363 |
| 0.1% |
| 7 | $1.81 | 300 | $545 | 0.2% |
| 8 | $1.82 | 300 | $546 | 0.2% |
| 9 | $1.82 | 100 | $182 | 0.1% |
| 10 | $1.80 | 25,188 | $45K | 12.7% |
| 11 | $1.81 | 6,400 | $12K | 3.3% |
| 12 | $1.81 | 200 | $363 | 0.1% |
| 13 | $1.82 | 25,100 | $46K | 12.8% |
| 14 | $1.82 | 200 | $364 | 0.1% |
| 15 | $1.83 | 800 | $1K | 0.4% |
| 16 | $1.84 | 15,000 | $28K | 7.7% |
| 17 | $1.85 | 40,200 | $74K | 20.9% |
| 18 | $1.86 | 9,800 | $18K | 5.1% |
| 19 | $1.87 | 14,165 | $26K | 7.4% |
| Total | $1.83 avg | 195,127 | $356K | 100% |
| Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |
| ATNM | SELL | 2016-07-07 | $38K | — | Filing → |